Fresenius | FRE - Current Assets


Fresenius reported EUR11.03B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Alcon AG USD 6.62B 171M Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
DaVita Healthcare Partners USD 4.06B 4.68M Mar/2026
Demant DKK 10.08B 128M Dec/2025
E.ON EUR 28.03B 5.75B Mar/2026
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Getinge SEK 18.16B 1.83B Dec/2024
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GN Store Nord DKK 4.85B 3.79B Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Philips EUR 9.78B 148M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
RWE EUR 45.61B 11.27B Mar/2026
Sanofi EUR 30.16B 789M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025